## Analysis of the PI Signaling Pathway ### Correct Statements (Options 0, 1, 2) **Option 0 — IP3 and Calcium Release:** **Key Point:** IP3 is a soluble second messenger that diffuses through the cytoplasm and binds to IP3 receptors (ligand-gated calcium channels) on the ER membrane, triggering Ca²⁺ release into the cytoplasm. This is a fundamental mechanism in signal transduction. **Option 1 — DAG and PKC Activation:** **Key Point:** DAG remains anchored in the plasma membrane (or ER membrane) and serves as a lipophilic activator of protein kinase C. PKC requires both DAG and calcium (or calcium-independent isoforms) for full activation. This is a canonical mechanism. **Option 2 — PLC Cleavage of PIP2:** **Key Point:** Phospholipase C (activated by GPCRs or receptor tyrosine kinases) hydrolyzes PIP2 into two second messengers: IP3 (soluble, diffusible) and DAG (membrane-bound). This is the initiating step of the PI cascade. ### Incorrect Statement (Option 3) — The Correct Answer **Warning:** Option 3 contains a **critical error**. While IP3 is indeed rapidly degraded by phosphatases (dephosphorylation to IP2, then IP1, then free inositol), the statement that "IP3 levels are maintained by continuous synthesis from free inositol via the Kennedy pathway" is **biochemically incorrect**. **High-Yield:** IP3 is NOT synthesized de novo from free inositol. Instead: 1. Free inositol is converted to inositol monophosphate (IP1) via inositol kinase 2. IP1 is phosphorylated to IP2, then IP3 via sequential kinase reactions 3. However, the **primary source** of IP3 is the **hydrolysis of PIP2 by phospholipase C**, not synthesis from free inositol 4. The "Kennedy pathway" (or myo-inositol synthesis pathway) is involved in replenishing the **phosphatidylinositol pool** in the membrane, not in generating IP3 directly 5. Free inositol is recycled back into phospholipids (via CDP-diacylglycerol pathway), not continuously converted to IP3 **Mnemonic:** **PIP2 → IP3 (not inositol → IP3)**. The second messenger IP3 comes from membrane phospholipid hydrolysis, not de novo synthesis from free inositol. ### Summary Table | Component | Source | Fate | Mechanism | | --- | --- | --- | --- | | **IP3** | PIP2 hydrolysis by PLC | Rapid phosphatase degradation to IP1, IP2, inositol | Diffuses to ER; binds IP3R; releases Ca²⁺ | | **DAG** | PIP2 hydrolysis by PLC | Phosphorylation to phosphatidic acid; re-acylation to PIP2 | Membrane-bound; activates PKC | | **Free inositol** | Dephosphorylation of IP1; dietary uptake | Re-incorporation into PIP2 via Kennedy pathway | Replenishes membrane PI pool | **Clinical Pearl:** Lithium inhibits inositol monophosphatase, blocking the recycling of IP1 back to free inositol. This depletes the PI pool and reduces PIP2 availability, which is why lithium has mood-stabilizing effects (and why patients on lithium need adequate dietary inositol).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.